Jorge Cortes, director of the Georgia Cancer Center at Augusta University, was selected as the inaugural editor-in-chief of the newest addition to the Blood journals portfolio: Blood Global Hematology.Â
The University of Cincinnati Cancer Center has opened the Blood Cancer Healing Center, a facility that aims to advance research, treatment, and wellness for blood cancer patients.Â
Thirty six early-career investigators received the the American Society of Hematology 2024 Scholar Awards.Â
Mohandas Narla, head of the laboratory of red cell physiology at New York Blood Center Enterprises, began his term as president of the American Society of Hematology. He will serve a year-long term through December 2024.
David Swoboda was named clinical director of leukemia at Tampa General Hospital Cancer Institute.
Imatinib—the pathbreaking cancer drug that gave Philadelphia chromosome-positive chronic myeloid leukemia patients near-normal life expectancies—now stands poised to save even more lives.Â
Richard Edelson began his career at NCI, where he was training to become a cancer immunologist.
OneOncology finalized 25 unique oncology and hematology pathways and published each pathway inside the platform’s clinical decision support tool.
Nina D’Abreo was named chief of the Division of Hematology and Medical Oncology at NYU Langone Health’s Perlmutter Cancer Center–Sunset Park, effective Sept. 1.
Christopher G. Cann was named an assistant professor in the Department of Hematology/Oncology with a focus on gastrointestinal cancers at Fox Chase Cancer Center.